<DOC>
	<DOCNO>NCT01938781</DOCNO>
	<brief_summary>Patients chronic hepatitis B histologically confirm liver fibrosis S2/S3 ( similar metavir F2/F3 , Ishak 2/3/4 ) randomly assign 1:1 ratio . One arm entecavir alone 2 year ; entecavir alone first 0.5 year , entecavir plus pegylated interferon ( peg-IFN ) 1 year , entecavir another additional 0.5 year . Patients assessed baseline , every six month blood count , liver function test , HBVDNA , AFP , prothrombin time , thyroid function , liver ultrasonography , Fibroscan . The second liver biopsy perform evaluate regression rate liver fibrosis 1.5 year initial therapy .</brief_summary>
	<brief_title>Optimized Treatment Regression HBV-induced Liver Fibrosis</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<mesh_term>Entecavir</mesh_term>
	<criteria>1 . Ages 18 65 year old ; 2 . Male female ; 3 . Treatmentnaive patient chronic HBVinduced fibrosis S2/S3 ( similar F2/F3 , Ishak 2/3/4 ) , consent undergo liver biopsy treatment ; 4 . Patients HBeAgpositive , HBVDNA &gt; 2×10 &lt; 4 &gt; IU/ml HBeAgnegative , HBVDNA &gt; 2×10 &lt; 3 &gt; IU/ml ; 5 . Agree followup regularly ; 6. signature write inform consent . 1 . Patients decompensated cirrhosis : include ascites , hepatic encephalopathy , esophageal varix bleed complication decompensated cirrhosis hepatocelluar carcinoma ; 2 . Patients allergic entecavir , interferon , component , consider suitable medication use study ; 3 . Patients coinfection HCV HIV , alcoholic liver disease , autoimmune liver disease , genetic liver disease , druginduced liver injury , severe nonalcoholic fatty liver disease chronic liver disease ; 4 . Patients baseline AFP level high 100 ng/ml possible malignant lesion image , AFP level high 100 ng/ml continuous three month ; 5 . Creatinine &gt; 1.5×ULN ; 6 . Patients uncured malignant tumor ; 7 . Patients severe disease heart , lung , kidney , brain , blood system organs ; 8 . Patients severe neurological psychological disease ( e.g . epilepsy , depression , mania schizophrenia ) ; 9 . Patients poorly control diabetes , hypertension thyroid disease ; 10 . Patients reason suitable study .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>Hepatitis B</keyword>
	<keyword>Liver fibrosis</keyword>
	<keyword>Regression</keyword>
	<keyword>Efficacy</keyword>
</DOC>